Skip to main content
. 2017 Feb 3;8(14):23353–23359. doi: 10.18632/oncotarget.15058

Figure 2. Positive expression of mTOR or beclin1 in the hippocampus of each group 24h after cerebral ischemia (immunohistochemical staining, 400x).

Figure 2

A1–D1: immunohistochemical results of beclin1 in the hippocampus for SO, I/R, IH+I/R and inhibitor group respectively. A2–D2: immunohistochemical results of mTOR in the hippocampus for SO, I/R, IH+I/R and inhibitor group respectively.